Synthesis and biological evaluation of some new benzimidazoles derivatives 4'-{5-amino-2-[2-substituted-phenylamino)-phenyl-methyl]-benzimidazol-1 ylmethyl}-biphenyl-2-carboxylic acid: Nonpeptide angiotensin II receptor antagonists.
Abstract:A new series of non peptide angiotensin (A-II) receptor antagonist has been prepared. This N-(biphenyl methyl) imidazoles e.g. Some new 4'-{5-amino-2-[2-substituted-phenylamino)-phenyl-methyl]-benzimidazol-1-ylmethyl}-biphenyl-2-carboxylic acid derivatives were synthesized by 2-( α -hydroxy benzyl) benzimidazole was converted to 2-(α-bromo benzyl) benzimidazole by reacting with HBr and Anhydrous ZnCl 2 Schiff bases react with biphenyl carboxylic acid with different substituents amino group cyclocondensation wi… Show more
“…Presence of amino group ( 224 ) has increased the activity substantially over the substituted one. The maximum activity has been observed with amino group .…”
Section: Antihypertensive Agentsmentioning
confidence: 90%
“…Presence of amino group (224) has increased the activity substantially over the substituted one. The maximum activity has been observed with amino group (238,239). Compound (226) was as active as albendazole against T. spiralis.…”
The properties of benzimidazole and its derivatives have been studied over more than one hundred years. Benzimidazole derivatives are useful intermediates/subunits for the development of molecules of pharmaceutical or biological interest. Substituted benzimidazole derivatives have found applications in diverse therapeutic areas such as antiulcer, anticancer agents, and anthelmintic species to name just a few. This work systematically gives a comprehensive review in current developments of benzimidazole-based compounds in the whole range of medicinal chemistry as anticancer, antibacterial, antifungal, anti-inflammatory, analgesic agents, anti-HIV, antioxidant, anticonvulsant, antitubercular, antidiabetic, antileishmanial, antihistaminic, antimalarial agents, and other medicinal agents. This review will further be helpful for the researcher on the basis of substitution pattern around the nucleus with an aim to help medicinal chemists for developing an SAR on benzimidazole drugs/compounds.
“…Presence of amino group ( 224 ) has increased the activity substantially over the substituted one. The maximum activity has been observed with amino group .…”
Section: Antihypertensive Agentsmentioning
confidence: 90%
“…Presence of amino group (224) has increased the activity substantially over the substituted one. The maximum activity has been observed with amino group (238,239). Compound (226) was as active as albendazole against T. spiralis.…”
The properties of benzimidazole and its derivatives have been studied over more than one hundred years. Benzimidazole derivatives are useful intermediates/subunits for the development of molecules of pharmaceutical or biological interest. Substituted benzimidazole derivatives have found applications in diverse therapeutic areas such as antiulcer, anticancer agents, and anthelmintic species to name just a few. This work systematically gives a comprehensive review in current developments of benzimidazole-based compounds in the whole range of medicinal chemistry as anticancer, antibacterial, antifungal, anti-inflammatory, analgesic agents, anti-HIV, antioxidant, anticonvulsant, antitubercular, antidiabetic, antileishmanial, antihistaminic, antimalarial agents, and other medicinal agents. This review will further be helpful for the researcher on the basis of substitution pattern around the nucleus with an aim to help medicinal chemists for developing an SAR on benzimidazole drugs/compounds.
“…The renin-angiotensin system plays a significant role in blood pressure control via the functions of angiotensin II which includes the release of nor-epinephrine, the secretion of aldosterone, the re-absorption of renal sodium, and vasoconstriction. Therefore, it can be considered a beneficial intervention in handling hypertension [ 4 ]. Among the hypertensive group of drugs, valsartan (2-(N-((2′-(2H-tetrazole-5-yl)-[1,1′-biphenyl]-4yl)-methyl)-pentanamido)-3-methyl butanoic acid) is one of the most commonly used drug moieties used in the treatment of hypertension [ 5 ].…”
This study aimed to evaluate 2-(N-((2′-(2H-tetrazole-5-yl)-[1,1′-biphenyl]-4yl)-methyl)-pentanamido)-3-methyl butanoic acid-based ester derivatives as a new class of angiotensin-II receptor antagonists. For this purpose, a series of compounds were synthesized using a variety of phenols. Their chemical characterization was established by FTIR, 1HNMR, and 13CNMR techniques. The biological activities including antioxidant potentials using the DPPH assay, the antihypertensive assay, the urease enzyme inhibition assay, and the antibacterial assay using agar well diffusion methods were performed. All the new compounds showed significant free radical scavenging potentials more than the parent drug while retaining antihypertensive potentials along with urease inhibition properties. However, the AV2 test compound was found to be the most potent against hypertension. Most of the synthesized analogs showed urease inhibitory actions. Molecular docking studies were performed for all the active analogs to decode the binding detail of the ligands with receptors of the enzyme’s active site.
“…In previous years, the research describing the importance of systems containing benzimidazole heterocyclic system was largely multiplied and covered vast bioactive activities including antimicrobial [1][2][3], antifungal 4, anti-inflammatory [5,6 ] antihelminthic [7], antitubercular 8,9, antithrombotic; antiplatelet and anticoagulant [10], antiulcer [11], antiprotozoal 12, antileishmanial 13, anti-inflammatory 14, antiviral 15 antimycobacterial 16, anti-HIV [17], antitumour [18]. Recently, benzimidazole target was reported as an anti-hypertensive agent [19,20], potent nonnucleoside reverse transcriptase inhibitors [21], inhibitors of the hepatitis C virus [22], anticonvulsant [23], ulcerogenic [24], nonpeptide angiotensin II receptor antagonists [25], potent activators of AMPactivated protein kinase [26] and antileukemic agents 27. R.V.…”
Novel complex derived from 2-aminomethylbenzimidazole, 2-(1H-benzimidazol-2-yl) aniline and metal chloride (Cd (II), Ni(II) and Cu(II)) was successfully synthesized. All newly complexes were fully characterized by spectroscopic data of FT-IR, UV-Visible electronic absorption, X-ray powder diffraction, and thermal analysis. IR spectra of the metal complexes revealed the coordination of the ligands to the metal ions via nitrogen atoms and mass spectra proposed that have a tetrahedral structure. The X-ray powder diffraction results affirmed that the Cu (II) complex has a triclinic structure, Cd (II) complex possess a triclinic structure and Ni (II) complex occupy a rhombohedral structure. The bioactivity score of tested compounds possesses a similar as compared to aspirin for all drug targets. The results of the theoretical toxicity study of different new complexes have been achieved based on program protox-II-prediction toxicity of chemicals and revealed that all target compounds exhibited no significant toxicity to all human cells.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.